RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+4.99%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$707M
AUM Growth
+$707M
(+26%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
15.03%
Top 10 Holdings %
Top 10 Hldgs %
27.95%
Holding
103
New
12
Increased
42
Reduced
34
Closed
6
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$18.6M |
| 2 |
UnitedHealth
UNH
|
$12.3M |
| 3 |
Cooper Companies
COO
|
$7.3M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
$7.03M |
| 5 |
Medtronic
MDT
|
$6.36M |
Top Sells
| 1 |
Amgen
AMGN
|
$4.61M |
| 2 |
OCR
OMNICARE INC
OCR
|
$3.85M |
| 3 |
Gilead Sciences
GILD
|
$3.4M |
| 4 |
Universal Health Services
UHS
|
$3.13M |
| 5 |
Ligand Pharmaceuticals
LGND
|
$3.01M |
Sector Composition
| 1 | Healthcare | 90.66% |
| 2 | Financials | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ionis Pharmaceuticals
IONS
$9.64B
| $5.41M | 0.65% |
94,000
-8,000
| -8% | -$460K |
|
|
ANTH
52
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $5.34M | 0.64% |
619,600
-81,714
| -12% | -$704K |
|
|
CLVS
53
DELISTED
Clovis Oncology, Inc.
CLVS
| $5.34M | 0.64% |
60,765
+6,765
| +13% | +$595K |
|
|
KERX
54
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $5.33M | 0.64% |
534,000
+237,000
| +80% | +$2.37M |
|
|
RCPT
55
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $5.32M | 0.64% |
28,000
-15,500
| -36% | -$2.95M |
|
|
MDVN
56
DELISTED
MEDIVATION, INC.
MDVN
| $5.25M | 0.63% |
46,000
-23,000
| -33% | -$2.63M |
|
57
Iovance Biotherapeutics
IOVA
$800M
| $5.1M | 0.61% |
+556,000
| New | +$5.1M |
|
|
TTPH
58
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $5.1M | 0.61% |
107,400
-14,600
| -12% | -$693K |
|
59
Celldex Therapeutics
CLDX
$1.57B
| $4.97M | 0.6% |
197,000
+78,000
| +66% | +$1.97M |
|
|
THOR
60
DELISTED
THORATEC CORPORATION
THOR
| $4.9M | 0.59% |
110,000
+23,000
| +26% | +$1.03M |
|
|
AMSG
61
DELISTED
Amsurg Corp
AMSG
| $4.9M | 0.59% |
70,000
-6,000
| -8% | -$420K |
|
62
Thermo Fisher Scientific
TMO
$183B
| $4.8M | 0.58% |
+37,000
| New | +$4.8M |
|
|
ENDP
63
DELISTED
Endo International plc
ENDP
| $4.7M | 0.56% |
58,976
+32,235
| +121% | +$2.57M |
|
64
Cencora
COR
$57.2B
| $4.47M | 0.54% |
42,000
+4,000
| +11% | +$425K |
|
65
Centene
CNC
$14.8B
| $4.34M | 0.52% |
54,000
+6,000
| +13% | +$482K |
|
66
Xencor
XNCR
$594M
| $4.13M | 0.5% |
188,000
-2,000
| -1% | -$43.9K |
|
67
MacroGenics
MGNX
$121M
| $4.1M | 0.49% |
107,959
+1,959
| +2% | +$74.4K |
|
|
KITE
68
DELISTED
Kite Pharma, Inc.
KITE
| $4.02M | 0.48% |
66,000
+21,000
| +47% | +$1.28M |
|
69
Edwards Lifesciences
EW
$47.7B
| $3.99M | 0.48% |
28,000
+9,000
| +47% | +$1.28M |
|
|
OREX
70
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $3.91M | 0.47% |
789,000
-42,800
| -5% | -$212K |
|
71
Halozyme
HALO
$8.75B
| $3.88M | 0.47% |
+172,000
| New | +$3.88M |
|
|
ZLTQ
72
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $3.8M | 0.46% |
+129,000
| New | +$3.8M |
|
|
ARIA
73
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $3.72M | 0.45% |
450,000
+63,000
| +16% | +$521K |
|
74
Hologic
HOLX
$14.7B
| $3.54M | 0.43% |
93,000
-8,000
| -8% | -$305K |
|
|
PTLA
75
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.46M | 0.42% |
+76,000
| New | +$3.46M |
|